IP Library Assignment 053938/0173
Patent Assignment
Reel/Frame 053938/0173

Assignment of Assignor's Interest

Recorded: 2020-09-30 Pages: 4
Assignor
I-MAB
Executed: 2019-10-14
Assignee
I-MAB BIOPHARMA US LIMITED
9801 WASHINGTONIAN BLVD., SUITE 710, GAITHERSBURG, MARYLAND, 20878
Covered Properties (2)
Anti-IFNAR1 Antibodies for Treating Autoimmune Diseases
Application: 16/963,128 →
Publication: US 2020/0399381
Anti-CXCL13 Antibodies
Application: 16/963,130 →
Publication: US 2020/0399360
Related Assignments (4)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Sep 21, 2020
From: CAO, WEI; XU, WEILI
To: I-MAB
Reel/Frame 053835/0564 →
Assignment of Assignor's Interest Sep 21, 2020
From: GU, HAIJUAN; YANG, QIUMEI
To: I-MAB
Reel/Frame 053835/0843 →
Assignment of Assignor's Interest Aug 30, 2021
From: I-MAB BIOPHARMA US LIMITED
To: I-MAB BIOPHARMA (HANGZHOU) CO., LTD.
Reel/Frame 057354/0325 →
Assignment of Assignor's Interest Jun 8, 2023
From: I-MAB BIOPHARMA US LIMITED
To: I-MAB BIOPHARMA CO., LTD.
Reel/Frame 063895/0973 →